Literature DB >> 22455398

Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52.

Ranganath Gopalakrishnan1, Christian Kozany, Yansong Wang, Sabine Schneider, Bastiaan Hoogeland, Andreas Bracher, Felix Hausch.   

Abstract

FK506-binding proteins (FKBP) 51 and 52 are cochaperones that modulate the signal transduction of steroid hormone receptors. Single nucleotide polymorphisms in the gene encoding FKBP51 have been associated with a variety of psychiatric disorders. Rapamycin and FK506 are two macrocyclic natural products, which tightly bind to most FKBP family members, including FKBP51 and FKBP52. A bioisosteric replacement of the α-ketoamide moiety of rapamycin and FK506 with a sulfonamide was envisaged with the retention of the conserved hydrogen bonds. A focused solid support-based synthesis protocol was developed, which led to ligands with submicromolar affinity for FKBP51 and FKBP52. The molecular binding mode for one sulfonamide analogue was confirmed by X-ray crystallography.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22455398     DOI: 10.1021/jm201747c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  FKBPs and the Akt/mTOR pathway.

Authors:  Felix Hausch; Christian Kozany; Marily Theodoropoulou; Anne-Katrin Fabian
Journal:  Cell Cycle       Date:  2013-07-01       Impact factor: 4.534

2.  Selective inhibitors of the FK506-binding protein 51 by induced fit.

Authors:  Steffen Gaali; Alexander Kirschner; Serena Cuboni; Jakob Hartmann; Christian Kozany; Georgia Balsevich; Christian Namendorf; Paula Fernandez-Vizarra; Claudia Sippel; Anthony S Zannas; Rika Draenert; Elisabeth B Binder; Osborne F X Almeida; Gerd Rühter; Manfred Uhr; Mathias V Schmidt; Chadi Touma; Andreas Bracher; Felix Hausch
Journal:  Nat Chem Biol       Date:  2014-12-01       Impact factor: 15.040

Review 3.  Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design.

Authors:  David M LeMaster; Griselda Hernandez
Journal:  Curr Mol Pharmacol       Date:  2015       Impact factor: 3.339

Review 4.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

5.  Large FK506-binding proteins shape the pharmacology of rapamycin.

Authors:  Andreas M März; Anne-Katrin Fabian; Christian Kozany; Andreas Bracher; Felix Hausch
Journal:  Mol Cell Biol       Date:  2013-01-28       Impact factor: 4.272

6.  Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.

Authors:  Andreas M Voll; Christian Meyners; Martha C Taubert; Thomas Bajaj; Tim Heymann; Stephanie Merz; Anna Charalampidou; Jürgen Kolos; Patrick L Purder; Thomas M Geiger; Pablo Wessig; Nils C Gassen; Andreas Bracher; Felix Hausch
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-07       Impact factor: 15.336

Review 7.  Precision pharmacotherapy: psychiatry's future direction in preventing, diagnosing, and treating mental disorders.

Authors:  Andreas Menke
Journal:  Pharmgenomics Pers Med       Date:  2018-11-19

8.  Crystal structure and conformational flexibility of the unligated FK506-binding protein FKBP12.6.

Authors:  Hui Chen; Sourajit M Mustafi; David M LeMaster; Zhong Li; Annie Héroux; Hongmin Li; Griselda Hernández
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-15

9.  Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52.

Authors:  Sourajit M Mustafi; David M LeMaster; Griselda Hernández
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

10.  Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine.

Authors:  Kai Hsin Liao; Kuen-Bao Chen; Wen-Yuan Lee; Mao-Feng Sun; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.